BlueMount Capital in Sydney, Australia | Business consultant

BlueMount Capital

Locality: Sydney, Australia

Phone: +61 2 8277 4112

Address: L 32 200 GEORGE STREET 2000 Sydney, NSW, Australia

Website: http://www.bluemountcapital.com

Likes: 112

Add/Update information

Reviews

Tags

• Financial service
• Business consultant
• Investing service

25.01.2022 The latest in BlueMount's series on US based companies listing on the ASX #ipos #asx: https://zcu.io/aIQb

23.01.2022 BlueMount Capital Opens Los Angeles USA Office Focus on Listing US Tech Firms on ASX. Read more here: https://zcu.io/RMqR

23.01.2022 "Simple supermarket ingredient behind innovative Australian COVID test" BlueMount Capital client XING on channel 9 news today. Read more here: https://zcu.io/Qe6b

22.01.2022 "XING Group seeks diagnostics JV partners; ready to release new COVID-19 test kit CEO" BlueMount Capital client XING features in Mergermarket article. Read more here: https://zcu.io/8BD1

21.01.2022 "Altech Chemicals Limited (ASX:ATC) (HAM:A3Y) is pleased to announce that it has initiated a listed green bond project funding option. The Company has mandated Bluemount Capital (WA) Pty Ltd (Bluemount)" Read more here: https://zcu.io/q8XH

19.01.2022 Project Fructus: A Secured Property Income Fund Opportunity Offering 12.75% p.a. Preference Unit Coupon Paid Monthly - find out more here: https://zcu.io/dP0c

18.01.2022 Congratulations to BlueMount Capital client Medcan Australia - First cultivation permits issued by the ODC (Office of Drug Control)! Read more here: https://zcu.io/pVw3

16.01.2022 Join BlueMount Capital client Medcan Australia CEO, Craig Cochran for a facility tour as he discusses the Australian Cultivation landscape from an industry perspective. With 34 industry speakers across the Australian Medicinal Cannabis space this is an event not to be missed

15.01.2022 Dr Mona Chung, Regional Director, China & Asia, for BlueMount Capital in Victoria, has recently released an audio interview titled "The impact of COVID-19 on international trade". Click here to listen: https://zcu.io/OTQW

13.01.2022 Healthcare and International Stock Exchange Listings for US companies https://zcu.io/eIOk

13.01.2022 Project Atramento An Australian company operating in the printing and printer consumables industries https://zcu.io/8ul9 #bluemountcapital #transactions #growthopportunity #expansion

13.01.2022 Altech Listed Green Bond Preparations Progressing Well: Altech is working closely with London based structuring agent, Bedford Row Capital PLC (Bedford Row) and Bluemount Capital (WA) Pty Ltd (Bluemount) to prepare for a Bond offering. Read more here: https://zcu.io/fRDs

11.01.2022 Watch as BlueMount Capital client Paul Mainwaring from XING Technologies shares with Tomorrow’s Tech, his advice for other entrepreneurs in the Medtech sector, on the value of collaboration for successful innovation. XING Technologies have received support from the Australian Government CSIRO, and United States NIH as they develop a 15-minute diagnosis, COVID-19 test.

06.01.2022 Looking to raise finance to grow your business or make an acquisition? Talk to us for a confidential appraisal. https://zcu.io/xGeq #finance #growth #assetfinance #capital #acquisition #bluemountcapital

06.01.2022 Corporate Finance https://zcu.io/rRdy

05.01.2022 Technology and International Stock Exchange Listings for US companies in Australia - read our latest news article here: https://zcu.io/1wGr

01.01.2022 XING Group seeks diagnostics JV partners; ready to release new COVID-19 test kit CEO https://zcu.io/NK5p